VeriChip Facility Gets Fresh ‘Certs
Delray Beach, Fla., RFID product manufacturer VeriChip’s Ottawa, Canada-based facility was recertified to the ISO 9001:2000 quality standard.
The facility is responsible for the design, manufacturing, sales, marketing, and support of VeriChip’s healthcare security and industrial products.
The ISO 9001:2000 standard specifies requirements for a quality management system in order for an organization to demonstrate its ability to consistently provide products that meet customer and regulatory requirements.
VeriChip’s Manufacturing Operations Quality System Re-Certified to ISO 9001:2000 Standard
Thursday December 7, 9:20 am ET
DELRAY BEACH, Fla., Dec. 7 /PRNewswire-FirstCall/ – Applied Digital Solutions (Nasdaq: ADSX – News), through its wholly owned subsidiary VeriChip Corporation, announced today that the quality system at its VeriChip facility in Ottawa, Canada, has been re-certified to the ISO 9001:2000 quality standard. The facility is responsible for the design, manufacture, sales, marketing and support of VeriChip’s healthcare security and industrial products.
The ISO 9000 family of standards has become an international reference for quality requirements in business-to-business dealings. ISO, the International Organization for Standardization, is the world’s largest developer of standards.
The ISO 9001:2000 standard specifies requirements for a quality management system in order for an organization to demonstrate its ability to consistently provide products that meet customer and regulatory requirements. Under the standard, VeriChip is required to develop and maintain a Quality Management System, and measure its results to ensure continuous improvement in its products and services.
The company’s Quality Management System was audited by QMI, North America’s leading management systems registrar. After an extensive audit, QMI re-certified VeriChip as being in compliance with the ISO 9001:2000 standard.
“Our certification to the ISO standard is a concrete sign of our commitment to give customers the best products and service,” said Daniel A. Gunther, President of VeriChip Corporation. “As the company continues to grow and expand, having a sound quality management system is essential to maintaining our reputation for excellence.”
For more information on VeriChip’s healthcare security products, please contact 1-866-559-6275 or email [email protected]. Additional information can be found online at www.verichiphealthcare.com. VeriChip’s instrumentation products are sold under the Instantel brand; please visit www.instantel.com.
About Applied Digital – “The Power of Identification Technology”
Applied Digital develops innovative identification and security products for consumer, commercial, and government sectors worldwide. The Company’s unique and often proprietary products provide identification and security systems for people, animals, the food supply, government/military arena, and commercial assets. Included in this diversified product line are RFID applications, end-to-end food safety systems, GPS/Satellite communications, and telecomm and security infrastructure, positioning Applied Digital as the leader in identification technology. Applied Digital is the owner of a majority position in Digital Angel Corporation (Amex: DOC – News).
About VeriChip Corporation
VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip’s goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. For more information on VeriChip, please call 1-800-970-2447, or email [email protected]. Additional information can be found online at www.verichipcorp.com.
